Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Zai Lab LTD Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$22.28 - $38.71 $142,592 - $247,744	6,400 Added 21.56%	36,082 $1.11 Million
Q1 2022 May 09, 2022	BUY	$27.77 - $64.4 $229,602 - $532,459	8,268 Added 38.61%	29,682 $1.31 Million
Q3 2021 Nov 04, 2021	BUY	$105.0 - $178.37 $290,325 - $493,193	2,765 Added 14.83%	21,414 $2.26 Million
Q2 2021 Aug 06, 2021	BUY	$125.11 - $180.0 $251,095 - $361,260	2,007 Added 12.06%	18,649 $3.3 Million
Q1 2021 May 06, 2021	BUY	$126.27 - $191.71 $221,730 - $336,642	1,756 Added 11.8%	16,642 $2.22 Million
Q4 2020 Feb 09, 2021	BUY	$81.94 - $135.34 $114,716 - $189,476	1,400 Added 10.38%	14,886 $2.02 Million
Q3 2020 Nov 10, 2020	BUY	$73.3 - $89.48 $211,543 - $258,239	2,886 Added 27.23%	13,486 $1.12 Million
Q2 2020 Aug 06, 2020	BUY	$48.82 - $82.53 $209,926 - $354,879	4,300 Added 68.25%	10,600 $871,000
Q1 2020 May 11, 2020	BUY	$39.1 - $62.9 $246,330 - $396,270	6,300 New	6,300 $324,000

Others Institutions Holding ZLAB

# of Institutions

121

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

Janus Henderson Group PLC London, X0

8.76M
Shares

$234 Million
0.11% of portfolio
Wellington Management Group LLP Boston, MA

8.44M
Shares

$225 Million
0.04% of portfolio
Capital World Investors Los Angeles, CA

6.44M
Shares

$172 Million
0.02% of portfolio
Viking Global Investors LP

1.95M
Shares

$52.1 Million
0.18% of portfolio
Bamco Inc New York, NY

1.91M
Shares

$50.9 Million
0.13% of portfolio

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.62B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account